[Preprint] Preliminary study shows Sinovac vaccine may not trigger sufficient antibody response to SARS-CoV-2 Lineage P.1

Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination – The Lancet

Commentary: Sinovac vaccine may not trigger sufficient antibody response to Brazil variant: study – Reuters

Commentary on Twitter

1) In a preprint (to the Lancet), the new Brazilian #SARSCoV2 variant P.1. was found to reduce the neutralizing ability of post-COVID-19 antibodies by about 6-fold, compared with the B lineage.https://t.co/obYmktWFXr pic.twitter.com/3IPiUjHB3l

— Jonathan Cedernaes (@JCedernaes) March 2, 2021